An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring systemJames Larkin, Christian U. Blank, Paolo A. Ascierto et al.|European Journal of Cancer|2018Cited by 14
Randomized, Double-Blind Study of Sonidegib (Lde225) in Patients (Pts) with Advanced Basal Cell Carcinoma (Bcc)Reinhard Dummer, Michael R. Migden, Alex Guminski et al.|Annals of Oncology|2014Cited by 2
Change in Fatigue and Correlations with Clinical Outcome in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib in the Bolt StudyAlex Guminski, Reinhard Dummer, D Stull et al.|Value in Health|2016Cited by 0